chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Burning sensation, Discomfort, Feeling abnormal, Mobility decreased
Clinical narrative: swelling, and "it moved": from the wrist, to the groin area to the thyroid area; left hand blew up like a balloon; I couldn't use my hand at all; couldn't use his hand at all, and it was very painful; Because of the pain I lost strength; In the thyroid area patient feels like a pressure, he feels it near his neck and throat and it is very uncomfortable; It is uncomfortable; burning sensation; general pain here and there; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling, and "it moved": from the wrist, to the groin area to the thyroid area), VACCINATION SITE SWELLING (left hand blew up like a balloon), MOBILITY DECREASED (I couldn't use my hand at all), VACCINATION SITE PAIN (couldn't use his hand at all, and it was very painful) and ASTHENIA (Because of the pain I lost strength) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced SWELLING (swelling, and "it moved": from the wrist, to the groin area to the thyroid area), VACCINATION SITE SWELLING (left hand blew up like a balloon), MOBILITY DECREASED (I couldn't use my hand at all), VACCINATION SITE PAIN (couldn't use his hand at all, and it was very painful), ASTHENIA (Because of the pain I lost strength), DISCOMFORT (In the thyroid area patient feels like a pressure, he feels it near his neck and throat and it is very uncomfortable), FEELING ABNORMAL (It is uncomfortable), BURNING SENSATION (burning sensation) and MYALGIA (general pain here and there). In 2021, MOBILITY DECREASED (I couldn't use my hand at all) and VACCINATION SITE PAIN (couldn't use his hand at all, and it was very painful) had resolved. At the time of the report, SWELLING (swelling, and "it moved": from the wrist, to the groin area to the thyroid area), VACCINATION SITE SWELLING (left hand blew up like a balloon), DISCOMFORT (In the thyroid area patient feels like a pressure, he feels it near his neck and throat and it is very uncomfortable), FEELING ABNORMAL (It is uncomfortable), BURNING SENSATION (burning sensation) and MYALGIA (general pain here and there) outcome was unknown and ASTHENIA (Because of the pain I lost strength) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.   This case was linked to MOD-2021-024056 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up information received and captured product details and additional events.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Swelling, Vaccination site pain, Vaccination site swelling
Clinical narrative: swelling, and "it moved": from the wrist, to the groin area to the thyroid area; left hand blew up like a balloon; I couldn't use my hand at all; couldn't use his hand at all, and it was very painful; Because of the pain I lost strength; In the thyroid area patient feels like a pressure, he feels it near his neck and throat and it is very uncomfortable; It is uncomfortable; burning sensation; general pain here and there; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling, and "it moved": from the wrist, to the groin area to the thyroid area), VACCINATION SITE SWELLING (left hand blew up like a balloon), MOBILITY DECREASED (I couldn't use my hand at all), VACCINATION SITE PAIN (couldn't use his hand at all, and it was very painful) and ASTHENIA (Because of the pain I lost strength) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced SWELLING (swelling, and "it moved": from the wrist, to the groin area to the thyroid area), VACCINATION SITE SWELLING (left hand blew up like a balloon), MOBILITY DECREASED (I couldn't use my hand at all), VACCINATION SITE PAIN (couldn't use his hand at all, and it was very painful), ASTHENIA (Because of the pain I lost strength), DISCOMFORT (In the thyroid area patient feels like a pressure, he feels it near his neck and throat and it is very uncomfortable), FEELING ABNORMAL (It is uncomfortable), BURNING SENSATION (burning sensation) and MYALGIA (general pain here and there). In 2021, MOBILITY DECREASED (I couldn't use my hand at all) and VACCINATION SITE PAIN (couldn't use his hand at all, and it was very painful) had resolved. At the time of the report, SWELLING (swelling, and "it moved": from the wrist, to the groin area to the thyroid area), VACCINATION SITE SWELLING (left hand blew up like a balloon), DISCOMFORT (In the thyroid area patient feels like a pressure, he feels it near his neck and throat and it is very uncomfortable), FEELING ABNORMAL (It is uncomfortable), BURNING SENSATION (burning sensation) and MYALGIA (general pain here and there) outcome was unknown and ASTHENIA (Because of the pain I lost strength) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.   This case was linked to MOD-2021-024056 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up information received and captured product details and additional events.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Headache, Malaise
Clinical narrative: Bad reaction; Not feeling well; Bad headache; A spontaneous report was received from a consumer, concerning herself, a 74-years-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced bad reaction, was not feeling well and had a bad headache.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unspecified date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection. On 22 Feb 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On 22 Feb 2021, after second dose of vaccination, all day Monday, the patient experienced bad reaction, bad headache and was not feeling well. Patient also had other health issues; no specifics were provided. No treatment information was provided.  Action taken with mRNA-1273 in response to the events were not reported.   The outcome of event bad reaction, bad headache and not feeling well were resolved on 24 Feb 2021.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema, Peripheral swelling, Pruritus, Vaccination site erythema, Vaccination site pain
Clinical narrative: Arm continued swelling 8 days later; Pain in arm at injection site; Arm red; Arm itchy; Arm puffy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in arm at injection site), VACCINATION SITE ERYTHEMA (Arm red), PRURITUS (Arm itchy), OEDEMA (Arm puffy) and PERIPHERAL SWELLING (Arm continued swelling 8 days later) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history Provided.).    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain in arm at injection site), VACCINATION SITE ERYTHEMA (Arm red), PRURITUS (Arm itchy) and OEDEMA (Arm puffy). On 08-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm continued swelling 8 days later). At the time of the report, VACCINATION SITE PAIN (Pain in arm at injection site), VACCINATION SITE ERYTHEMA (Arm red), PRURITUS (Arm itchy), OEDEMA (Arm puffy) and PERIPHERAL SWELLING (Arm continued swelling 8 days later) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient has taken treatment and applied anti itch cream concomitant medicataion for blood pressure
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Euphoric mood, Fatigue, Pain in extremity, Somnolence
Clinical narrative: arm was sore; low, low energy; almost went to sleep; felt very sleepy; felt high; very tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), ASTHENIA (low, low energy), SOMNOLENCE (almost went to sleep; felt very sleepy), EUPHORIC MOOD (felt high) and FATIGUE (very tired) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was sore), ASTHENIA (low, low energy), SOMNOLENCE (almost went to sleep; felt very sleepy), EUPHORIC MOOD (felt high) and FATIGUE (very tired). At the time of the report, PAIN IN EXTREMITY (arm was sore), ASTHENIA (low, low energy), SOMNOLENCE (almost went to sleep; felt very sleepy), EUPHORIC MOOD (felt high) and FATIGUE (very tired) outcome was unknown.            Concomitant medication included thyroid medication. No treatment information was provided.   This case was linked to MOD-2021-027173 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Additional information was received on 21-May-2021. Contact details updated (email updated).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Hypertension, Tinnitus
Clinical narrative: Blood pressure was 203; Pulse was 113; ear ringing; A spontaneous report was received from a Healthcare Professional concerning a 69-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events blood pressure was 203, her pulse was 113, ear ringing.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 015M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 4 Feb 2021, the patient experienced the events blood pressure was 203. her pulse was 113, ear ringing.  Treatment details included She doubled the dose of lisinopril 5mg  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, blood pressure was 203, On an unknown date the outcome of events, her pulse was 113, On an unknown date the outcome of events, ear ringing was not reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchiness at the injection site; Rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE RASH (Rash at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included Lupus syndrome (Lupus for almost 40 years.) since an unknown date. Concurrent medical conditions included Dermatomyositis (atypical dermatomyositis). Concomitant products included LISINOPRIL, MULTIVITAMINS [VITAMINS NOS], FOLIC ACID, VITAMIN D NOS, CYANOCOBALAMIN (VIT B12), VITAMIN C [ASCORBIC ACID], CALCIUM and ATORVASTATIN for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE RASH (Rash at the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE RASH (Rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   As treatment the patient used some scentless cream on skin.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: No consent for further follow up.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Lethargy, Nervousness, Pyrexia, Vertigo
Clinical narrative: feels shaky; vertigo; slight fever; Dizziness; he feels lethargic; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), LETHARGY (he feels lethargic), VERTIGO (vertigo), NERVOUSNESS (feels shaky) and PYREXIA (slight fever) in a 75-year-old male patient who received  .    Co-suspect product included mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.    No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced DIZZINESS (Dizziness), LETHARGY (he feels lethargic) and PYREXIA (slight fever). On 19-Feb-2021, the patient experienced VERTIGO (vertigo). On an unknown date, the patient experienced NERVOUSNESS (feels shaky). At the time of the report, DIZZINESS (Dizziness), LETHARGY (he feels lethargic), VERTIGO (vertigo), NERVOUSNESS (feels shaky) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included meclizine 25 Mg   This case was linked to MOD21-084284 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Non Significant FU received; Sender's Comments:  MOD21-084284:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Back pain, Fatigue, Malaise, Pain in extremity
Clinical narrative: Sick to Stomach; head feels like it weighs 50lbs"; Arm Pain; Back Pain; not feeling very well"; swelling/hardness at the Injection site; Fatigue/tiredness; swelling/hardness at the Injection site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Sick to Stomach), TENSION HEADACHE (head feels like it weighs 50lbs"), PAIN IN EXTREMITY (Arm Pain), BACK PAIN (Back Pain) and MALAISE (not feeling very well") in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal and Cholesterol total abnormal NOS. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN), ACETYLSALICYLIC ACID (BABY ASPIRIN), HYDRALAZINE and CHORIONIC GONADOTROPHIN (PROVIGIL [CHORIONIC GONADOTROPHIN]) for an unknown indication.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (Sick to Stomach), TENSION HEADACHE (head feels like it weighs 50lbs"), PAIN IN EXTREMITY (Arm Pain), BACK PAIN (Back Pain), MALAISE (not feeling very well"), VACCINATION SITE INDURATION (swelling/hardness at the Injection site), FATIGUE (Fatigue/tiredness) and VACCINATION SITE SWELLING (swelling/hardness at the Injection site). At the time of the report, ABDOMINAL DISCOMFORT (Sick to Stomach), TENSION HEADACHE (head feels like it weighs 50lbs"), PAIN IN EXTREMITY (Arm Pain), BACK PAIN (Back Pain), MALAISE (not feeling very well"), VACCINATION SITE INDURATION (swelling/hardness at the Injection site), FATIGUE (Fatigue/tiredness) and VACCINATION SITE SWELLING (swelling/hardness at the Injection site) had not resolved.            Concomitant medications were provided as Blood Pressure Meds and Cholesterol Pill.  No Treatment information provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow up contains no new information.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Tension headache, Vaccination site induration, Vaccination site swelling
Clinical narrative: Sick to Stomach; head feels like it weighs 50lbs"; Arm Pain; Back Pain; not feeling very well"; swelling/hardness at the Injection site; Fatigue/tiredness; swelling/hardness at the Injection site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Sick to Stomach), TENSION HEADACHE (head feels like it weighs 50lbs"), PAIN IN EXTREMITY (Arm Pain), BACK PAIN (Back Pain) and MALAISE (not feeling very well") in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal and Cholesterol total abnormal NOS. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN), ACETYLSALICYLIC ACID (BABY ASPIRIN), HYDRALAZINE and CHORIONIC GONADOTROPHIN (PROVIGIL [CHORIONIC GONADOTROPHIN]) for an unknown indication.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (Sick to Stomach), TENSION HEADACHE (head feels like it weighs 50lbs"), PAIN IN EXTREMITY (Arm Pain), BACK PAIN (Back Pain), MALAISE (not feeling very well"), VACCINATION SITE INDURATION (swelling/hardness at the Injection site), FATIGUE (Fatigue/tiredness) and VACCINATION SITE SWELLING (swelling/hardness at the Injection site). At the time of the report, ABDOMINAL DISCOMFORT (Sick to Stomach), TENSION HEADACHE (head feels like it weighs 50lbs"), PAIN IN EXTREMITY (Arm Pain), BACK PAIN (Back Pain), MALAISE (not feeling very well"), VACCINATION SITE INDURATION (swelling/hardness at the Injection site), FATIGUE (Fatigue/tiredness) and VACCINATION SITE SWELLING (swelling/hardness at the Injection site) had not resolved.            Concomitant medications were provided as Blood Pressure Meds and Cholesterol Pill.  No Treatment information provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow up contains no new information.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Nasopharyngitis, Paraesthesia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips), PARAESTHESIA (Tingling sensation in nose and lips) and COUGH (Coughing) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (aspirin), Sulfonamide allergy, Allergic to cats, Allergic to dogs, Drug allergy, Drug allergy and Drug allergy.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips), PARAESTHESIA (Tingling sensation in nose and lips) and FATIGUE (Felt tired,tiredness). On 21-Jan-2021, the patient experienced COUGH (Coughing), PRODUCTIVE COUGH (Bringing up yellow "stuff" when coughing), NASOPHARYNGITIS (Blowing nose a little bit), PYREXIA (Fever 100.3), CHILLS (Chills) and VACCINATION SITE PAIN (Pain at site of injection). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of UNK dosage form and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips) and PARAESTHESIA (Tingling sensation in nose and lips) had resolved and COUGH (Coughing), PRODUCTIVE COUGH (Bringing up yellow "stuff" when coughing), NASOPHARYNGITIS (Blowing nose a little bit), PYREXIA (Fever 100.3), FATIGUE (Felt tired,tiredness), CHILLS (Chills) and VACCINATION SITE PAIN (Pain at site of injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Pyrexia: 100.3 (High) 100.3.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Productive cough, Pyrexia, Swelling face, Swelling of eyelid
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips), PARAESTHESIA (Tingling sensation in nose and lips) and COUGH (Coughing) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (aspirin), Sulfonamide allergy, Allergic to cats, Allergic to dogs, Drug allergy, Drug allergy and Drug allergy.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips), PARAESTHESIA (Tingling sensation in nose and lips) and FATIGUE (Felt tired,tiredness). On 21-Jan-2021, the patient experienced COUGH (Coughing), PRODUCTIVE COUGH (Bringing up yellow "stuff" when coughing), NASOPHARYNGITIS (Blowing nose a little bit), PYREXIA (Fever 100.3), CHILLS (Chills) and VACCINATION SITE PAIN (Pain at site of injection). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of UNK dosage form and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips) and PARAESTHESIA (Tingling sensation in nose and lips) had resolved and COUGH (Coughing), PRODUCTIVE COUGH (Bringing up yellow "stuff" when coughing), NASOPHARYNGITIS (Blowing nose a little bit), PYREXIA (Fever 100.3), FATIGUE (Felt tired,tiredness), CHILLS (Chills) and VACCINATION SITE PAIN (Pain at site of injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Pyrexia: 100.3 (High) 100.3.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips), PARAESTHESIA (Tingling sensation in nose and lips) and COUGH (Coughing) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (aspirin), Sulfonamide allergy, Allergic to cats, Allergic to dogs, Drug allergy, Drug allergy and Drug allergy.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips), PARAESTHESIA (Tingling sensation in nose and lips) and FATIGUE (Felt tired,tiredness). On 21-Jan-2021, the patient experienced COUGH (Coughing), PRODUCTIVE COUGH (Bringing up yellow "stuff" when coughing), NASOPHARYNGITIS (Blowing nose a little bit), PYREXIA (Fever 100.3), CHILLS (Chills) and VACCINATION SITE PAIN (Pain at site of injection). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of UNK dosage form and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SWELLING OF EYELID (Slight eye lid swelling, both eyes), SWELLING FACE (Face swelling), PARAESTHESIA ORAL (Tingling sensation in nose and lips) and PARAESTHESIA (Tingling sensation in nose and lips) had resolved and COUGH (Coughing), PRODUCTIVE COUGH (Bringing up yellow "stuff" when coughing), NASOPHARYNGITIS (Blowing nose a little bit), PYREXIA (Fever 100.3), FATIGUE (Felt tired,tiredness), CHILLS (Chills) and VACCINATION SITE PAIN (Pain at site of injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Pyrexia: 100.3 (High) 100.3.
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: Sinus infection headache; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced SINUSITIS (Sinus infection headache). At the time of the report, SINUSITIS (Sinus infection headache) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Contact information provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site inflammation
Clinical narrative: injection site bruised; injection site hard; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (injection site bruised) and INJECTION SITE INFLAMMATION (injection site hard) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE BRUISING (injection site bruised) and INJECTION SITE INFLAMMATION (injection site hard). At the time of the report, INJECTION SITE BRUISING (injection site bruised) and INJECTION SITE INFLAMMATION (injection site hard) outcome was unknown. Not Provided          No concomitant medications were provided. Treatment medications were unknown.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Nausea
Clinical narrative: diarrhea; fever; chills; joint pain; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (joint pain) and FATIGUE (fatigue) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02523948) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced DIARRHOEA (diarrhea), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (joint pain), FATIGUE (fatigue) and NAUSEA (nausea). On 07-Jan-2021, DIARRHOEA (diarrhea), CHILLS (chills) and NAUSEA (nausea) had resolved. On 08-Jan-2021, PYREXIA (fever), ARTHRALGIA (joint pain) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: diarrhea; fever; chills; joint pain; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (joint pain) and FATIGUE (fatigue) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02523948) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced DIARRHOEA (diarrhea), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (joint pain), FATIGUE (fatigue) and NAUSEA (nausea). On 07-Jan-2021, DIARRHOEA (diarrhea), CHILLS (chills) and NAUSEA (nausea) had resolved. On 08-Jan-2021, PYREXIA (fever), ARTHRALGIA (joint pain) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Symptom recurrence, Vaccination site urticaria
Clinical narrative: hives then returned; Hives at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SYMPTOM RECURRENCE (hives then returned) and VACCINATION SITE URTICARIA (Hives at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Hives at the injection site). On 28-Jan-2021, the patient experienced SYMPTOM RECURRENCE (hives then returned). At the time of the report, SYMPTOM RECURRENCE (hives then returned) outcome was unknown and VACCINATION SITE URTICARIA (Hives at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: red spot just below the injection site with 4 to 5 cm in diamete; Swollen; Itchy; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (red spot just below the injection site with 4 to 5 cm in diamete), SWELLING (Swollen) and PRURITUS (Itchy) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ERYTHEMA (red spot just below the injection site with 4 to 5 cm in diamete), SWELLING (Swollen) and PRURITUS (Itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 24-Jan-2021, ERYTHEMA (red spot just below the injection site with 4 to 5 cm in diamete), SWELLING (Swollen) and PRURITUS (Itchy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information include Antibiotics and anti inflammatory like Ibuprofen, Benadryl.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warmness at the injection site; Itchiness at the injection site; 2 1/2 inch pink area surrounding the injection site; Arm was sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmness at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (2 1/2 inch pink area surrounding the injection site) and VACCINATION SITE PAIN (Arm was sore at injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore at injection site). On 24-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warmness at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE ERYTHEMA (2 1/2 inch pink area surrounding the injection site). At the time of the report, VACCINATION SITE WARMTH (Warmness at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (2 1/2 inch pink area surrounding the injection site) and VACCINATION SITE PAIN (Arm was sore at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information include Ice pack.   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: Follow-up received on 22-Mar-2021 included no new information. On 08-Apr-2021: Follow-up received on 08-Apr-2021 included no new information.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Gait disturbance, Headache, Malaise
Clinical narrative: not able to walk without support; sore arm; Not felling 100 percent since vaccine; dizzy; Feeling terrible; nausea; vomiting; headache; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (not able to walk without support), PAIN IN EXTREMITY (sore arm), ASTHENIA (Not felling 100 percent since vaccine), DIZZINESS (dizzy) and MALAISE (Feeling terrible) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (not able to walk without support), PAIN IN EXTREMITY (sore arm), ASTHENIA (Not felling 100 percent since vaccine), DIZZINESS (dizzy), MALAISE (Feeling terrible), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache). At the time of the report, GAIT DISTURBANCE (not able to walk without support), PAIN IN EXTREMITY (sore arm), ASTHENIA (Not felling 100 percent since vaccine), DIZZINESS (dizzy), MALAISE (Feeling terrible), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Vomiting
Clinical narrative: not able to walk without support; sore arm; Not felling 100 percent since vaccine; dizzy; Feeling terrible; nausea; vomiting; headache; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (not able to walk without support), PAIN IN EXTREMITY (sore arm), ASTHENIA (Not felling 100 percent since vaccine), DIZZINESS (dizzy) and MALAISE (Feeling terrible) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (not able to walk without support), PAIN IN EXTREMITY (sore arm), ASTHENIA (Not felling 100 percent since vaccine), DIZZINESS (dizzy), MALAISE (Feeling terrible), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache). At the time of the report, GAIT DISTURBANCE (not able to walk without support), PAIN IN EXTREMITY (sore arm), ASTHENIA (Not felling 100 percent since vaccine), DIZZINESS (dizzy), MALAISE (Feeling terrible), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Pain in extremity
Clinical narrative: Loss of taste; Loss of smell; Soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste), ANOSMIA (Loss of smell) and PAIN IN EXTREMITY (Soreness in her arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025X20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included SIMVASTATIN (CHOLESTROL) for Hyperlipidemia, LISINOPRIL and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her arm). On 26-Jan-2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). At the time of the report, AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) had not resolved and PAIN IN EXTREMITY (Soreness in her arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jan-2021: Follow up received on 28-MAY-2021 and it contains No newinformation
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: sore right arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore right arm) and HEADACHE (headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L204) for COVID-19 vaccination.     Concurrent medical conditions included Migraine and Cholesterol. Concomitant products included BUPROPION, GABAPENTIN, LEVOTHYROXINE SODIUM (OROXINE), FAMOTIDINE and OLMESARTAN for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore right arm) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore right arm) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not reported.   This case was linked to MOD-2021-247917, MOD-2021-247917 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: TCR - NNI about case.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site warmth
Clinical narrative: Size of a egg; Warm to the touch; Appeared red; Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Size of a egg), VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Appeared red) and VACCINATION SITE PAIN (Sore) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE MASS (Size of a egg), VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Appeared red) and VACCINATION SITE PAIN (Sore). At the time of the report, VACCINATION SITE MASS (Size of a egg), VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Appeared red) and VACCINATION SITE PAIN (Sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow-up information received on 12-Apr-2021 included no new information.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the se events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Vaccination site swelling
Clinical narrative: swelling face; swelling arm of injection; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (swelling face) and VACCINATION SITE SWELLING (swelling arm of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (swelling face) and VACCINATION SITE SWELLING (swelling arm of injection). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, SWELLING FACE (swelling face) and VACCINATION SITE SWELLING (swelling arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants were reported.   This case was linked to MOD-2021-020217 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-May-2021: Follow up received on 22-May-2021 contains non significant information, response to ADR. Unable to identify patient. Reporter address updated. On 24-May-2021: Follow up received on 24-May-2021 contains no new information; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: Slight elevation in blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Slight elevation in blood pressure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (Slight elevation in blood pressure). At the time of the report, HYPERTENSION (Slight elevation in blood pressure) had not resolved.            No treatment information was provided.  No concomitant medication was provided.    This case was linked to MOD-2021-025858 (Patient Link).